DMK
LKFT

David M. Knott’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

David M. Knott’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$105K Hold
2,000
– – 0.04% 116
2021
Q2 		$138K Buy
2,000
+1,000
+100% +$76.3K 0.05% 110
2021
Q1 		$77K Buy
+1,000
New +$92.1K 0.03% 109

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

David M. Knott's LKFT Position: Q3 2021 in Review

David M. Knott held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q3 2021 at 2,000 shares worth $105K. The position accounts for 0.04% of the portfolio, ranked #116.

David M. Knott first reported a position in LKFT in Q1 2021 and has held it in 3 quarters since. The position peaked at $138K in Q2 2021. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

  • David M. Knott held 2,000 shares of Lakefront Biotherapeutics American Depositary Shares worth $105K as of Q3 2021.
  • David M. Knott left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q3 2021.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.04% of David M. Knott's portfolio in Q3 2021, its #116 holding.
  • David M. Knott first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and has held it in 3 quarters since.
  • David M. Knott's Lakefront Biotherapeutics American Depositary Shares position peaked at $138K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.